{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:50:51Z","timestamp":1777035051862,"version":"3.51.4"},"reference-count":87,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ejps.2011.12.003","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T10:42:03Z","timestamp":1323686523000},"page":"367-378","source":"Crossref","is-referenced-by-count":8,"title":["Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As2O3 and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3\/AsR"],"prefix":"10.1016","volume":"45","author":[{"given":"Pei-Shi","family":"Ong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sui-Yung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2011.12.003_b0005","doi-asserted-by":"crossref","first-page":"E4728","DOI":"10.1371\/journal.pone.0004728","article-title":"The role of MMP7 and its cross-talk with the FAS\/FASL system during the acquisition of chemoresistance to oxaliplatin","volume":"4","author":"Almendro","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2011.12.003_b0010","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1159\/000242253","article-title":"Local expression of insulin-like growth factor-I, insulin-like growth factor-I receptor, and estrogen receptor alpha in ovarian cancer","volume":"32","author":"An","year":"2009","journal-title":"Onkologie"},{"key":"10.1016\/j.ejps.2011.12.003_b0015","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/sj.bjc.6602596","article-title":"Reduced expression of chemokine (C\u2013C motif) ligand-2 (CCL2) in ovarian adenocarcinoma","volume":"92","author":"Arnold","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejps.2011.12.003_b0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/156800908784533445","article-title":"S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast","volume":"8","author":"Arai","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejps.2011.12.003_b0025","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/j.1525-1438.2006.00626.x","article-title":"Arsenic trioxide exposure to ovarian carcinoma cells leads to decreased level of topoisomerase II and cytotoxicity","volume":"16","author":"Askar","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ejps.2011.12.003_b0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1359-6101(98)00018-5","article-title":"The interleukin 1 receptor: ligand interactions and signal transduction","volume":"9","author":"Auron","year":"1998","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejps.2011.12.003_b0035","first-page":"249","article-title":"The insulin-like growth factor I receptor: a key to tumor growth?","volume":"55","author":"Baserga","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate \u2013 a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Statist. Soc. B"},{"key":"10.1016\/j.ejps.2011.12.003_b0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on bias and variance","volume":"19","author":"Bolstad","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejps.2011.12.003_b0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1541-7786.257.2.5","article-title":"Human tissue kallikreins: physiologic roles and applications in cancer","volume":"2","author":"Borgo\u00f1o","year":"2004","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/368419a0","article-title":"Physiological consequences of loss of plasminogen activator gene function in mice","volume":"368","author":"Carmeliet","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2011.12.003_b0060","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","article-title":"In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha\/PML proteins","volume":"88","author":"Chen","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2011.12.003_b0065","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V93.1.268","article-title":"Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system","volume":"93","author":"Dai","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2011.12.003_b0070","first-page":"L163","article-title":"Regulation of cellular glutathione","volume":"257","author":"Deneke","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejps.2011.12.003_b0075","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1309\/AJCPTK87EMMIKPFS","article-title":"S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival","volume":"132","author":"DeRycke","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ejps.2011.12.003_b0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/08830189809043005","article-title":"Interleukin-1, interleukin-1 receptors, and interleukin-1 receptor antagonist","volume":"16","author":"Dinarello","year":"1998","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.ejps.2011.12.003_b0085","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/gast.2002.31885","article-title":"Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells","volume":"122","author":"D\u00edaz","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2011.12.003_b0090","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1158\/0008-5472.CAN-09-3415","article-title":"Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma","volume":"70","author":"Dong","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0095","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1186\/1471-2407-10-672","article-title":"Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression","volume":"10","author":"Dozmorov","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejps.2011.12.003_b0100","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s002800100278","article-title":"Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines","volume":"47","author":"Du","year":"2001","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2011.12.003_b0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1381612043453559","article-title":"The urokinase plasminogen activator system: role in malignancy","volume":"10","author":"Duffy","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2011.12.003_b0110","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00384-009-0725-z","article-title":"Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer","volume":"24","author":"Fang","year":"2009","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.ejps.2011.12.003_b0115","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.biocel.2005.02.025","article-title":"Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells","volume":"37","author":"Fitzgerald","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejps.2011.12.003_b0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/ERC-08-0250","article-title":"Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer","volume":"16","author":"Gallego","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ejps.2011.12.003_b0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting","volume":"278","author":"Gialeli","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.ejps.2011.12.003_b0130","first-page":"1321","article-title":"P57: a multifunctional protein in cancer","volume":"36","author":"Guo","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejps.2011.12.003_b0135","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexcr.2005.10.013","article-title":"S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells","volume":"312","author":"Hermani","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0140","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/ncb1507","article-title":"Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis","volume":"8","author":"Hiratsuka","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejps.2011.12.003_b0145","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/gut.2006.097188","article-title":"Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells","volume":"56","author":"Hurtado","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.ejps.2011.12.003_b0150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejps.2011.12.003_b0155","doi-asserted-by":"crossref","first-page":"11471","DOI":"10.1158\/0008-5472.CAN-06-1448","article-title":"17\u03b2-Hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor positive breast cancer","volume":"66","author":"Jansson","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejps.2011.12.003_b0435","doi-asserted-by":"crossref","first-page":"13756","DOI":"10.1073\/pnas.0404727101","article-title":"Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo","volume":"101","author":"Jessani","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejps.2011.12.003_b0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3727\/096504009789954672","article-title":"Identification of genes with differential expression in chemoresistant epithelial ovarian cancer using high-density oligonucleotide microarrays","volume":"18","author":"Ju","year":"2009","journal-title":"Oncol. Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0170","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2741\/1034","article-title":"The insulin-like growth factor\/insulin system in epithelial ovarian cancer","volume":"8","author":"Kalli","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejps.2011.12.003_b0175","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/(SICI)1097-0215(19970807)72:4<687::AID-IJC22>3.0.CO;2-7","article-title":"Leukemia inhibitory factor induces apoptosis and proliferation of human carcinoma cells through different oncogene pathways","volume":"72","author":"Kamohara","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejps.2011.12.003_b0180","first-page":"977","article-title":"Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: involvement of regulation of LIF and its receptor expression","volume":"30","author":"Kamohara","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejps.2011.12.003_b0185","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s13277-011-0163-8","article-title":"Prognostic impact of S100A9 overexpression in non-small cell lung cancer","volume":"32","author":"Kawai","year":"2011","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ejps.2011.12.003_b0190","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-0215(19960516)66:4<515::AID-IJC15>3.0.CO;2-6","article-title":"Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways","volume":"66","author":"Kellokumpu-Lehtinen","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejps.2011.12.003_b0195","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1074\/jbc.M410542200","article-title":"IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor\/JAK\/STAT pathway in medullary thyroid carcinoma cells","volume":"280","author":"Kim","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2011.12.003_b0200","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1525-1438.2005.00251.x","article-title":"Arsenic trioxide induces apoptosis in cisplatin-sensitive and -resistant ovarian cancer cell lines","volume":"15","author":"Kong","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ejps.2011.12.003_b0205","first-page":"5","article-title":"Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors","volume":"29","author":"L\u2019Esp\u00e9rance","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejps.2011.12.003_b0210","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3835(03)00159-9","article-title":"The insulin-like growth factor system and cancer","volume":"195","author":"LeRoith","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejps.2011.12.003_b0215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1479-5876-4-48","article-title":"Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment","volume":"4","author":"Lewis","year":"2006","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejps.2011.12.003_b0220","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/mol.62.3.529","article-title":"Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines","volume":"62","author":"Ling","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2011.12.003_b0225","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1755-8794-3-37","article-title":"The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel","volume":"3","author":"Liu","year":"2010","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.ejps.2011.12.003_b0230","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ejps.2011.12.003_b0235","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1177\/106002809502901213","article-title":"Glutathione in health and disease: pharmacotherapeutic issues","volume":"29","author":"Lomaestro","year":"1995","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejps.2011.12.003_b0240","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2165\/00003495-200868060-00004","article-title":"Pharmaceutical management of ovarian cancer: current status","volume":"68","author":"Markman","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2011.12.003_b0245","first-page":"5","article-title":"The interleukin-1 receptor complex and interleukin-1 signal transduction","volume":"8","author":"Martin","year":"1997","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.ejps.2011.12.003_b0250","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2007.04.007","article-title":"Expression and biological role of the prostaglandin D synthase\/SOX9 pathway in human ovarian cancer cells","volume":"255","author":"Malki","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejps.2011.12.003_b0255","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1517\/14728220903277256","article-title":"CIAP2 as a therapeutic target in colorectal cancer and other malignancies","volume":"13","author":"Miura","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejps.2011.12.003_b0260","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1525-1438.2000.00018.x","article-title":"Emergence of cisplatin-resistant cells from the OVCAR-3 ovarian carcinoma cell line with p53 mutations, altered tumorigenicity, and increased apoptotic sensitivity to p53 gene replacement","volume":"10","author":"Mujoo","year":"2000","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ejps.2011.12.003_b0265","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ajh.20656","article-title":"IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes","volume":"81","author":"Nakagawa","year":"2006","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejps.2011.12.003_b0270","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/bioinformatics\/btg290","article-title":"Pathway studio \u2013 the analysis and navigation of molecular networks","volume":"19","author":"Nikitin","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejps.2011.12.003_b0275","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.pharmtox.43.100901.140229","article-title":"Regulatory mechanisms controlling gene expression mediated by the antioxidant response element","volume":"43","author":"Nguyen","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2011.12.003_b0280","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1517\/14728220903512983","article-title":"Targeting CCL11 in the treatment of ovarian cancer","volume":"14","author":"Nolen","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejps.2011.12.003_b0285","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1158\/0008-5472.CAN-04-0446","article-title":"17\u03b2-Hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer","volume":"64","author":"Oduwole","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0290","first-page":"1731","article-title":"Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation","volume":"38","author":"Ong","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejps.2011.12.003_b0295","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2353\/ajpath.2007.060850","article-title":"Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1\/2 activation through epidermal growth factor receptor and annexin A2","volume":"170","author":"Ortiz-Zapater","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejps.2011.12.003_b0300","first-page":"954","article-title":"Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid","volume":"119","author":"Passeron","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2011.12.003_b0305","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.2009.03700.x","article-title":"Steroid hormone transforming aldo-keto reductases and cancer","volume":"1155","author":"Penning","year":"2009","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ejps.2011.12.003_b0310","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/hq0701.093685","article-title":"Role of matrix metalloproteinase and plasminogen activator\u2013plasmin systems in angiogenesis","volume":"21","author":"Pepper","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejps.2011.12.003_b0315","doi-asserted-by":"crossref","first-page":"955","DOI":"10.4161\/auto.6.7.13041","article-title":"SnoN\/SkiL, a TGF\u03b2 signaling mediator: a participant in autophagy induced by arsenic trioxide","volume":"6","author":"Raffoul","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.ejps.2011.12.003_b0320","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mce.2005.10.009","article-title":"AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer","volume":"248","author":"Rizner","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejps.2011.12.003_b0325","first-page":"1153","article-title":"Human kallikrein 8 (hK8\/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer","volume":"11","author":"Shigemasa","year":"2004","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejps.2011.12.003_b0330","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000089290","article-title":"Downregulation of human kallikrein 10 (KLK10\/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers","volume":"26","author":"Sidiropoulos","year":"2005","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ejps.2011.12.003_b0335","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.4049\/jimmunol.178.7.4222","article-title":"Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance","volume":"178","author":"Simson","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2011.12.003_b0340","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/cdd.2010.53","article-title":"Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN\/SkiL expression in ovarian carcinoma cells","volume":"17","author":"Smith","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejps.2011.12.003_b0430","first-page":"1998","article-title":"Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain","volume":"53","author":"Stack","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0345","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3638::AID-ELPS3638>3.0.CO;2-W","article-title":"Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma","volume":"20","author":"Stul\u00edk","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ejps.2011.12.003_b0350","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/(SICI)1522-2683(19990101)20:4\/5<1047::AID-ELPS1047>3.0.CO;2-E","article-title":"The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass","volume":"20","author":"Stul\u00edk","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ejps.2011.12.003_b0355","first-page":"3191","article-title":"Expression of p57kip2 and its clinical relevance in epithelial ovarian tumors","volume":"22","author":"Sui","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0360","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/pr101154j","article-title":"Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer","volume":"10","author":"Sung","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0365","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1349-7006.2010.01506.x","article-title":"Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer","volume":"101","author":"Szarvas","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejps.2011.12.003_b0370","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3835(01)00724-8","article-title":"Induced transcriptional expression of calcium-binding protein S100A1 and S100A10 genes in human renal cell carcinoma","volume":"175","author":"Teratani","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejps.2011.12.003_b0375","first-page":"4957","article-title":"Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines","volume":"6","author":"Uslu","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0380","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1568009023333863","article-title":"Insulin-like growth factor receptor-1 as an anti-cancer target: blocking transformation and inducing apoptosis","volume":"2","author":"Wang","year":"2002","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejps.2011.12.003_b0385","first-page":"1812","article-title":"IL (Interleukin)-1a promotes nuclear factor-kB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas","volume":"7","author":"Wolf","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0390","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.onc.1209986","article-title":"Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling","volume":"26","author":"Wong","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ejps.2011.12.003_b0395","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1158\/0008-5472.CAN-06-1021","article-title":"Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas","volume":"67","author":"Wysoczynski","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0400","doi-asserted-by":"crossref","first-page":"49446","DOI":"10.1074\/jbc.M209372200","article-title":"Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(\u2212\/\u2212) knockout mouse. Novel model system for a severely compromised oxidative stress response","volume":"277","author":"Yang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2011.12.003_b0405","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2559.2008.03068.x","article-title":"Expression of leukaemia inhibitory factor in epithelial ovarian carcinoma: correlation with clinical characteristics","volume":"53","author":"Ye","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.ejps.2011.12.003_b0410","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s10620-009-0926-x","article-title":"Elevated serum matrix metalloproteinase-3 and -7 in H. Pylori-related gastric cancer can be biomarkers correlating with a poor survival","volume":"55","author":"Yeh","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejps.2011.12.003_b0415","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02977781","article-title":"Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells","volume":"30","author":"Yong","year":"2007","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejps.2011.12.003_b0420","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ygyno.2006.02.037","article-title":"Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo","volume":"103","author":"Zhang","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejps.2011.12.003_b0425","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/j.1349-7006.2009.01340.x","article-title":"Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer","volume":"100","author":"Zhang","year":"2009","journal-title":"Cancer Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098711004350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098711004350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T14:34:14Z","timestamp":1742049254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098711004350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0928098711004350"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2011.12.003","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}